Sageworth Trust’s Mesoblast MESO Stock Holding History

Sageworth Trust’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$125K	–	105
2025 Q1	$125K	Hold	10,000	–	–	0.01%	96
2024 Q4	$198K	Buy	+10,000	New	+$111K	0.01%	96

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SXL

Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Sageworth Trust's MESO Position: Q2 2025 in Review

Sageworth Trust sold out of Mesoblast (MESO) in Q2 2025, closing a stake of 10,000 shares — an estimated $125K sold.

Sageworth Trust first reported a position in MESO in Q4 2024 and held it in 2 quarters. The position peaked at $198K in Q4 2024. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2025.

Sageworth Trust reported no remaining Mesoblast position as of Q2 2025 after selling out during the quarter.
Sageworth Trust sold 10,000 Mesoblast shares in Q2 2025, an estimated $125K.
Sageworth Trust first reported a position in Mesoblast in Q4 2024 and held it in 2 quarters.
Sageworth Trust's Mesoblast position peaked at $198K in Q4 2024.
72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2025.

Based on Sageworth Trust's 13F filing for Q2 2025, filed 21 Jul 2025.